Study of the Orsiro Drug Eluting Stent System
NCT01356888
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
452
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
Percutaneous Coronary Intervention (Abbott Laboratories - Xience Prime DES)
DEVICE:
Percutaneous Coronary Intervention (Orsiro DES)
Sponsor
Biotronik AG